Literature DB >> 2968613

The dopamine D2 receptor agonists, quinpirole and bromocriptine produce conditioned place preferences.

D C Hoffman1, P R Dickson, R J Beninger.   

Abstract

1. The conditioned place preference paradigm was used to examine the role of the D2 receptor in mediating the reinforcing effects of dopamine (DA) agonists. 2. During the 3-day pre-exposure phase, rats explored two distinctive end compartments which were adjoined by a small tunnel. During the 8-day conditioning phase, groups of rats were treated with the selective D2 receptor agonists, quinpirole (0.01, 0.025, 0.05, 0.10, 0.25, 1.0 and 5.0 mg/kg IP) or bromocriptine (0, 0.01, 0.1, 0.5, 1.0, 5.0 and 10.0 mg/kg IP) and confined to one compartment for 30 min. On alternate days, rats received vehicle injections and were placed in the opposite compartment. Test days occurred over the remaining 3 days during which untreated animals explored both compartments. 3. Rats conditioned with quinpirole or bromocriptine showed significant increases in time spent in the drug-paired environment from pre-exposure to test indicating the establishment of conditioned place preferences. 4. This suggests a functional role for the D2 receptor in mediating the rewarding effects of DA agonists.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2968613     DOI: 10.1016/0278-5846(88)90050-4

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  11 in total

Review 1.  Hypocretin/orexin involvement in reward and reinforcement.

Authors:  Rodrigo A España
Journal:  Vitam Horm       Date:  2012       Impact factor: 3.421

Review 2.  Dopamine and addiction: what have we learned from 40 years of research.

Authors:  Marcello Solinas; Pauline Belujon; Pierre Olivier Fernagut; Mohamed Jaber; Nathalie Thiriet
Journal:  J Neural Transm (Vienna)       Date:  2018-12-19       Impact factor: 3.575

3.  Dopamine D1 receptor activation induces dehydroepiandrosterone sulfotransferase (SULT2A1) in HepG2 cells.

Authors:  Jiao-Jiao Xu; Si-Yuan Wang; Ye Chen; Guang-Ping Chen; Zai-Quan Li; Xue-Yan Shao; Liang Li; Wei Lu; Tian-Yan Zhou
Journal:  Acta Pharmacol Sin       Date:  2014-06-09       Impact factor: 6.150

4.  Subsensitivity to rewarding and locomotor stimulant effects of a dopamine agonist following chronic mild stress.

Authors:  M Papp; R Muscat; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  NMDA or AMPA/kainate receptor blockade prevents acquisition of conditioned place preference induced by D(2/3) dopamine receptor stimulation in rats.

Authors:  Anna-Maria Biondo; Robert L H Clements; David J Hayes; Brendan Eshpeter; Andrew J Greenshaw
Journal:  Psychopharmacology (Berl)       Date:  2005-03-03       Impact factor: 4.530

Review 6.  The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction.

Authors:  James P Burkett; Larry J Young
Journal:  Psychopharmacology (Berl)       Date:  2012-08-11       Impact factor: 4.530

7.  Pramipexole induced place preference after L-dopa therapy and nigral dopaminergic loss: linking behavior to transcriptional modifications.

Authors:  Simon Loiodice; Poppy Winlow; Sarah Dremier; Etienne Hanon; David Dardou; Omar Ouachikh; Aziz Hafidi; Andre Nogueira da Costa; Franck Durif
Journal:  Psychopharmacology (Berl)       Date:  2016-09-10       Impact factor: 4.530

8.  Histamine H3 receptor antagonist JNJ-39220675 modulates locomotor responses but not place conditioning by dopaminergic drugs.

Authors:  Jenni Vanhanen; Marja Kinnunen; Saara Nuutinen; Pertti Panula
Journal:  Psychopharmacology (Berl)       Date:  2014-10-12       Impact factor: 4.530

9.  Bromocriptine enhancement of responding for conditioned reward depends on intact D1 receptor function.

Authors:  R Ranaldi; R J Beninger
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

10.  Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat.

Authors:  C B Hubner; J E Moreton
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.